People · Operator
Named in public records as an officer, director or promoter · active 2011–2018 · Biotechnology, Other Technology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Synergy Biomedical, LLC | — | Biotechnology | Pre-Seed | $1.2M | $33.8M | 2011 |
| Respirogen, Inc. | — | Other Technology | Pre-Seed | $750K | $10.6M | 2018 |
Mark Borden at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Mark Borden on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| David Anderson | 1 | 21 |
| Richard Kienzle | 1 | 3 |
| Robert Scribner | 1 | 2 |
| Robert M. Scribner | 1 | 2 |
| Mark M Borden | 1 | 1 |
| Paul M Mountford | 1 | 1 |
| Paul Mountford | 1 | 1 |
| Glenn Kenney | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.